Stock-Based Compensation (Tables)
|
9 Months Ended |
Sep. 30, 2026 |
| Share-Based Payment Arrangement [Abstract] |
|
| Summary of Stock Option Activity |
The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2026:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Shares |
|
|
Weighted- Average Exercise Price per share |
|
|
Weighted- Average Remaining Contractual Term (in years) |
|
|
Aggregate Intrinsic Value (in thousands) |
|
Balance at December 31, 2025 |
|
6,287,477 |
|
|
$ |
12.23 |
|
|
|
8.62 |
|
|
$ |
113,839 |
|
Granted |
|
2,230,527 |
|
|
|
28.92 |
|
|
|
|
|
|
|
Exercised |
|
(361,827 |
) |
|
|
11.36 |
|
|
|
|
|
|
|
Forfeited |
|
(201,239 |
) |
|
|
21.27 |
|
|
|
|
|
|
|
Options outstanding at September 30, 2026 |
|
7,954,938 |
|
|
$ |
16.72 |
|
|
|
8.28 |
|
|
$ |
135,181 |
|
Options vested and exercisable at September 30, 2026 |
|
3,340,172 |
|
|
|
12.34 |
|
|
|
7.89 |
|
|
|
71,006 |
|
Options vested and expected to vest at September 30, 2026 |
|
7,954,938 |
|
|
$ |
16.72 |
|
|
|
8.28 |
|
|
$ |
135,181 |
|
|
| Summary of Restricted Stock Awards Grant Activity |
The following table summarizes the Company’s service-based RSA grant activity for the nine months ended September 30, 2026:
|
|
|
|
|
|
|
|
|
RSAs |
|
|
Weighted- Average Grant Date Fair Value |
|
Unvested shares at December 31, 2025 |
|
411,833 |
|
|
$ |
3.94 |
|
Granted |
|
— |
|
|
|
— |
|
Vested |
|
(252,684 |
) |
|
|
3.87 |
|
Forfeited |
|
(28,846 |
) |
|
|
2.92 |
|
Unvested shares at September 30, 2026 |
|
130,303 |
|
|
$ |
4.28 |
|
|
| Summary of Performance-based RSA Grant Activity |
The following table summarizes the Company’s performance-based RSA grant activity for the nine months ended September 30, 2026:
|
|
|
|
|
|
|
|
|
RSAs |
|
|
Weighted- Average Grant Date Fair Value |
|
Unvested shares at December 31, 2025 |
|
212,977 |
|
|
$ |
3.72 |
|
Granted |
|
— |
|
|
|
— |
|
Vested |
|
(123,274 |
) |
|
|
3.81 |
|
Forfeited |
|
(24,129 |
) |
|
|
2.92 |
|
Unvested shares at September 30, 2026 |
|
65,574 |
|
|
$ |
3.85 |
|
|
| Summary of Restricted Stock Unit Activity |
The following table summarizes restricted stock unit activity for the nine months ended September 30, 2026 and provides information for unvested shares as of September 30, 2026.
|
|
|
|
|
|
|
|
|
RSUs |
|
|
Weighted- Average Grant Date Fair Value |
|
Unvested shares at December 31, 2025 |
|
13,987 |
|
|
$ |
7.15 |
|
Granted |
|
10,000 |
|
|
|
31.67 |
|
Vested |
|
(6,994 |
) |
|
|
7.15 |
|
Forfeited |
|
— |
|
|
|
— |
|
Unvested shares at September 30, 2026 |
|
16,993 |
|
|
$ |
21.58 |
|
|
| Summary of Share-based Compensation Expense |
The following table summarizes the classification of the Company’s stock-based compensation expense in the condensed consolidated statements of operations and comprehensive loss (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
For the Three Months Ended September 30, |
|
|
For the Nine Months Ended September 30, |
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Selling, general and administrative |
|
$ |
4,665 |
|
|
$ |
3,037 |
|
|
$ |
13,136 |
|
|
$ |
8,536 |
|
Research and development |
|
|
2,969 |
|
|
|
1,698 |
|
|
|
8,663 |
|
|
|
4,628 |
|
|
|
$ |
7,634 |
|
|
$ |
4,735 |
|
|
$ |
21,799 |
|
|
$ |
13,164 |
|
|